Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer
- 22 March 2011
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (10) , 2912-2918
Abstract
We sought to examine how splenectomy as part of up-front cytoreductive surgery in ovarian cancer influences the postoperative course and affects survival. We reviewed cases of ovarian cancer diagnosed at Massachusetts General Hospital from 1994 to 2008 and found 44 patients who had a splenectomy as part of their up-front cytoreductive surgery. These were compared to 171 patients who did not undergo splenectomy. We evaluated age at diagnosis, estimated blood loss, percentage of patients whose disease was optimally cytoreduced (P < 0.045), respectively. The addition of splenectomy to up-front cytoreductive surgery was feasible and safe. However, it appears to carry with it a shortened survival that is unrelated to postoperative morbidity. Our data raise the questions that splenectomy is needed for optimal cytoreduction in more biologically aggressive disease and that splenectomy may be an independent prognostic factor related to depressed immune function.Keywords
This publication has 32 references indexed in Scilit:
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory SitesScience, 2009
- The effect of spleen‐preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancerJournal of Surgical Oncology, 2009
- Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapyWorld Journal of Surgical Oncology, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?Gynecologic Oncology, 2001
- Impact of Splenectomy for Lymph Node Dissection on Long-Term Surgical Outcome in Gastric CancerAnnals of Surgical Oncology, 2001
- Splenectomy and Surgical Cytoreduction for Ovarian CancerGynecologic Oncology, 2000
- End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinomaSurgery, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Splenectomy as Part of Cytoreductive Surgery for Ovarian CarcinomaGynecologic Oncology, 1995